Pharmaniaga Berhad Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	126.28	114.74	52.85	47.11
Short-Term Investments	258.57	8.57	2.87	4.11	10.25
Cash & Short-Term Investments	258.57	134.85	117.61	56.96	57.36
Cash Growth	91.76%	14.66%	106.48%	-0.70%	40.85%
Accounts Receivable	446.69	337.63	285.22	261.75	227.85
Other Receivables	29.16	86.96	84.4	76.77	44.1
Receivables	475.85	424.58	369.62	338.52	271.95
Inventory	729.82	612.79	580.64	767.26	1,264
Prepaid Expenses	-	12.27	26.9	32.06	27.52
Restricted Cash	-	19.8	12.7	-	-
Total Current Assets	1,464	1,204	1,107	1,195	1,621
Property, Plant & Equipment	602.78	609.36	605.75	443.03	395.59
Goodwill	77.03	77.31	77.47	77.34	129.48
Other Intangible Assets	13.55	74.01	72.09	72.39	75.31
Long-Term Deferred Tax Assets	28.15	27.34	52.08	48.89	33.07
Long-Term Deferred Charges	61.08	-	-	10.83	3.23
Total Assets	2,247	1,992	1,915	1,847	2,258
Accounts Payable	898	650.1	627.78	648.02	677.63
Accrued Expenses	0.4	96.19	91.6	46.78	31.53
Short-Term Debt	527.49	771.26	711.18	681.3	543.98
Current Portion of Long-Term Debt	162.55	283.41	335.87	384.45	25.7
Current Portion of Leases	3.99	4.48	4.62	5.67	1.57
Current Income Taxes Payable	6.97	10.46	9.8	4.27	14.44
Current Unearned Revenue	11.69	29.76	9.16	31.28	22.46
Other Current Liabilities	-	107.43	212.44	265.93	150.46
Total Current Liabilities	1,611	1,953	2,002	2,068	1,468
Long-Term Debt	125.4	129.57	138.62	91.67	284.99
Long-Term Leases	0.37	3.18	1.09	5	0.62
Long-Term Unearned Revenue	15.22	14.51	3.1	3.36	3.62
Pension & Post-Retirement Benefits	10.56	10.79	10.84	9.05	9.08
Long-Term Deferred Tax Liabilities	25.05	27.13	32.85	18.82	21.35
Total Liabilities	1,788	2,138	2,189	2,196	1,787
Common Stock	243.43	200.05	200.05	154.19	154.05
Retained Earnings	97.06	-471.41	-603.42	-525.23	293.73
Comprehensive Income & Other	93.98	100.09	104.31	1.34	2.69
Total Common Equity	434.47	-171.28	-299.07	-369.69	450.46
Minority Interest	24.69	25.33	24.98	21.39	19.98
Shareholders' Equity	459.16	-145.94	-274.09	-348.31	470.44
Total Liabilities & Equity	2,247	1,992	1,915	1,847	2,258
Total Debt	819.79	1,192	1,191	1,168	856.86
Net Cash (Debt)	-561.22	-1,057	-1,074	-1,111	-799.5
Net Cash Per Share	-0.16	-0.73	-0.79	-0.85	-0.61
Filing Date Shares Outstanding	3,614	1,441	1,441	1,310	1,310
Total Common Shares Outstanding	3,614	1,441	1,441	1,310	1,310
Working Capital	-146.85	-748.78	-894.98	-872.9	153.43
Book Value Per Share	0.12	-0.12	-0.21	-0.28	0.34
Tangible Book Value	343.89	-322.59	-448.62	-519.43	245.68
Tangible Book Value Per Share	0.10	-0.22	-0.31	-0.40	0.19
Land	-	393.11	394.01	25.66	25.55
Buildings	-	-	-	254.02	255.22
Machinery	-	503.2	497.02	444.29	430.76
Construction In Progress	-	125.81	109.28	75.42	30.17

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.